TMC435350-TIDP16-C106: A PHASE I TRIAL TO COMPARE THE BIOAVAILABILITY AND PLASMA PHARMACOKINETICS AFTER A SINGLE ORAL DOSE OF TMC435350 OF 2 DIFFERENT SOLID FORMULATIONS RELATIVE TO A POWDER BLEND CAPSULE: